Global Parkinson Disease Drug Market Size, Status and Forecast 2022

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.

Market Analysis and Insights: Global Parkinson Disease Drug Market

In 2021, the global Parkinson Disease Drug market size will be US$ million and it is expected to reach US$ million by the end of 2027, with a CAGR of % during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parkinson Disease Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parkinson Disease Drug market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parkinson Disease Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parkinson Disease Drug market.

Global Parkinson Disease Drug Scope and Market Size

Parkinson Disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Sinemet-CR

Trastal

Madopar

COMT Inhibitor

Other

Under 40 Years Old

40-65 Years Old

Above 65 Years Old

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Merck

Akorn

GSK

Novartis

Boehringer Ingelheim

Teva Pharmaceutical

Abbvie

Kyowa Hakko Kirin Pharma

Astellas Pharma

Desitin Arzneimittel

Endo Pharmaceuticals

F.Hoffmann-La Roche

H.Lundbeck

Valeant

Apokyn

Orion

Stada Arzneimittel

US WorldMeds

Bausch Health

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Parkinson Disease Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Sinemet-CR

1.2.3 Trastal

1.2.4 Madopar

1.2.5 COMT Inhibitor

1.2.6 Other

1.3 Market by Application

1.3.1 Global Parkinson Disease Drug Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Under 40 Years Old

1.3.3 40-65 Years Old

1.3.4 Above 65 Years Old

1.4 Study Objectives

1.5 Years Considered

2.1 Global Parkinson Disease Drug Market Perspective (2016-2027)

2.2 Parkinson Disease Drug Growth Trends by Regions

2.2.1 Parkinson Disease Drug Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Parkinson Disease Drug Historic Market Share by Regions (2016-2021)

2.2.3 Parkinson Disease Drug Forecasted Market Size by Regions (2022-2027)

2.3 Parkinson Disease Drug Industry Dynamic

2.3.1 Parkinson Disease Drug Market Trends

2.3.2 Parkinson Disease Drug Market Drivers

2.3.3 Parkinson Disease Drug Market Challenges

2.3.4 Parkinson Disease Drug Market Restraints

3.1 Global Top Parkinson Disease Drug Players by Revenue

3.1.1 Global Top Parkinson Disease Drug Players by Revenue (2016-2021)

3.1.2 Global Parkinson Disease Drug Revenue Market Share by Players (2016-2021)

3.2 Global Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Parkinson Disease Drug Revenue

3.4 Global Parkinson Disease Drug Market Concentration Ratio

3.4.1 Global Parkinson Disease Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Parkinson Disease Drug Revenue in 2020

3.5 Parkinson Disease Drug Key Players Head office and Area Served

3.6 Key Players Parkinson Disease Drug Product Solution and Service

3.7 Date of Enter into Parkinson Disease Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Parkinson Disease Drug Historic Market Size by Type (2016-2021)

4.2 Global Parkinson Disease Drug Forecasted Market Size by Type (2022-2027)

5.1 Global Parkinson Disease Drug Historic Market Size by Application (2016-2021)

5.2 Global Parkinson Disease Drug Forecasted Market Size by Application (2022-2027)

6.1 North America Parkinson Disease Drug Market Size (2016-2027)

6.2 North America Parkinson Disease Drug Market Size by Type

6.2.1 North America Parkinson Disease Drug Market Size by Type (2016-2021)

6.2.2 North America Parkinson Disease Drug Market Size by Type (2022-2027)

6.2.3 North America Parkinson Disease Drug Market Size by Type (2016-2027)

6.3 North America Parkinson Disease Drug Market Size by Application

6.3.1 North America Parkinson Disease Drug Market Size by Application (2016-2021)

6.3.2 North America Parkinson Disease Drug Market Size by Application (2022-2027)

6.3.3 North America Parkinson Disease Drug Market Size by Application (2016-2027)

6.4 North America Parkinson Disease Drug Market Size by Country

6.4.1 North America Parkinson Disease Drug Market Size by Country (2016-2021)

6.4.2 North America Parkinson Disease Drug Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7.1 Europe Parkinson Disease Drug Market Size (2016-2027)

7.2 Europe Parkinson Disease Drug Market Size by Type

7.2.1 Europe Parkinson Disease Drug Market Size by Type (2016-2021)

7.2.2 Europe Parkinson Disease Drug Market Size by Type (2022-2027)

7.2.3 Europe Parkinson Disease Drug Market Size by Type (2016-2027)

7.3 Europe Parkinson Disease Drug Market Size by Application

7.3.1 Europe Parkinson Disease Drug Market Size by Application (2016-2021)

7.3.2 Europe Parkinson Disease Drug Market Size by Application (2022-2027)

7.3.3 Europe Parkinson Disease Drug Market Size by Application (2016-2027)

7.4 Europe Parkinson Disease Drug Market Size by Country

7.4.1 Europe Parkinson Disease Drug Market Size by Country (2016-2021)

7.4.2 Europe Parkinson Disease Drug Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8.1 Asia-Pacific Parkinson Disease Drug Market Size (2016-2027)

8.2 Asia-Pacific Parkinson Disease Drug Market Size by Type

8.2.1 Asia-Pacific Parkinson Disease Drug Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Parkinson Disease Drug Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Parkinson Disease Drug Market Size by Type (2016-2027)

8.3 Asia-Pacific Parkinson Disease Drug Market Size by Application

8.3.1 Asia-Pacific Parkinson Disease Drug Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Parkinson Disease Drug Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Parkinson Disease Drug Market Size by Application (2016-2027)

8.4 Asia-Pacific Parkinson Disease Drug Market Size by Region

8.4.1 Asia-Pacific Parkinson Disease Drug Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Parkinson Disease Drug Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Parkinson Disease Drug Market Size (2016-2027)

9.2 Latin America Parkinson Disease Drug Market Size by Type

9.2.1 Latin America Parkinson Disease Drug Market Size by Type (2016-2021)

9.2.2 Latin America Parkinson Disease Drug Market Size by Type (2022-2027)

9.2.3 Latin America Parkinson Disease Drug Market Size by Type (2016-2027)

9.3 Latin America Parkinson Disease Drug Market Size by Application

9.3.1 Latin America Parkinson Disease Drug Market Size by Application (2016-2021)

9.3.2 Latin America Parkinson Disease Drug Market Size by Application (2022-2027)

9.3.3 Latin America Parkinson Disease Drug Market Size by Application (2016-2027)

9.4 Latin America Parkinson Disease Drug Market Size by Country

9.4.1 Latin America Parkinson Disease Drug Market Size by Country (2016-2021)

9.4.2 Latin America Parkinson Disease Drug Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Parkinson Disease Drug Market Size (2016-2027)

10.2 Middle East & Africa Parkinson Disease Drug Market Size by Type

10.2.1 Middle East & Africa Parkinson Disease Drug Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Parkinson Disease Drug Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Parkinson Disease Drug Market Size by Type (2016-2027)

10.3 Middle East & Africa Parkinson Disease Drug Market Size by Application

10.3.1 Middle East & Africa Parkinson Disease Drug Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Parkinson Disease Drug Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Parkinson Disease Drug Market Size by Application (2016-2027)

10.4 Middle East & Africa Parkinson Disease Drug Market Size by Country

10.4.1 Middle East & Africa Parkinson Disease Drug Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Parkinson Disease Drug Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Parkinson Disease Drug Introduction

11.1.4 Merck Revenue in Parkinson Disease Drug Business (2016-2021)

11.1.5 Merck Recent Development

11.2 Akorn

11.2.1 Akorn Company Details

11.2.2 Akorn Business Overview

11.2.3 Akorn Parkinson Disease Drug Introduction

11.2.4 Akorn Revenue in Parkinson Disease Drug Business (2016-2021)

11.2.5 Akorn Recent Development

11.3 GSK

11.3.1 GSK Company Details

11.3.2 GSK Business Overview

11.3.3 GSK Parkinson Disease Drug Introduction

11.3.4 GSK Revenue in Parkinson Disease Drug Business (2016-2021)

11.3.5 GSK Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Parkinson Disease Drug Introduction

11.4.4 Novartis Revenue in Parkinson Disease Drug Business (2016-2021)

11.4.5 Novartis Recent Development

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Details

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Parkinson Disease Drug Introduction

11.5.4 Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2016-2021)

11.5.5 Boehringer Ingelheim Recent Development

11.6 Teva Pharmaceutical

11.6.1 Teva Pharmaceutical Company Details

11.6.2 Teva Pharmaceutical Business Overview

11.6.3 Teva Pharmaceutical Parkinson Disease Drug Introduction

11.6.4 Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2016-2021)

11.6.5 Teva Pharmaceutical Recent Development

11.7 Abbvie

11.7.1 Abbvie Company Details

11.7.2 Abbvie Business Overview

11.7.3 Abbvie Parkinson Disease Drug Introduction

11.7.4 Abbvie Revenue in Parkinson Disease Drug Business (2016-2021)

11.7.5 Abbvie Recent Development

11.8 Kyowa Hakko Kirin Pharma

11.8.1 Kyowa Hakko Kirin Pharma Company Details

11.8.2 Kyowa Hakko Kirin Pharma Business Overview

11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Introduction

11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2016-2021)

11.8.5 Kyowa Hakko Kirin Pharma Recent Development

11.9 Astellas Pharma

11.9.1 Astellas Pharma Company Details

11.9.2 Astellas Pharma Business Overview

11.9.3 Astellas Pharma Parkinson Disease Drug Introduction

11.9.4 Astellas Pharma Revenue in Parkinson Disease Drug Business (2016-2021)

11.9.5 Astellas Pharma Recent Development

11.10 Desitin Arzneimittel

11.10.1 Desitin Arzneimittel Company Details

11.10.2 Desitin Arzneimittel Business Overview

11.10.3 Desitin Arzneimittel Parkinson Disease Drug Introduction

11.10.4 Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2016-2021)

11.10.5 Desitin Arzneimittel Recent Development

11.11 Endo Pharmaceuticals

11.11.1 Endo Pharmaceuticals Company Details

11.11.2 Endo Pharmaceuticals Business Overview

11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Introduction

11.11.4 Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2016-2021)

11.11.5 Endo Pharmaceuticals Recent Development

11.12 F.Hoffmann-La Roche

11.12.1 F.Hoffmann-La Roche Company Details

11.12.2 F.Hoffmann-La Roche Business Overview

11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Introduction

11.12.4 F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2016-2021)

11.12.5 F.Hoffmann-La Roche Recent Development

11.13 H.Lundbeck

11.13.1 H.Lundbeck Company Details

11.13.2 H.Lundbeck Business Overview

11.13.3 H.Lundbeck Parkinson Disease Drug Introduction

11.13.4 H.Lundbeck Revenue in Parkinson Disease Drug Business (2016-2021)

11.13.5 H.Lundbeck Recent Development

11.14 Valeant

11.14.1 Valeant Company Details

11.14.2 Valeant Business Overview

11.14.3 Valeant Parkinson Disease Drug Introduction

11.14.4 Valeant Revenue in Parkinson Disease Drug Business (2016-2021)

11.14.5 Valeant Recent Development

11.15 Apokyn

11.15.1 Apokyn Company Details

11.15.2 Apokyn Business Overview

11.15.3 Apokyn Parkinson Disease Drug Introduction

11.15.4 Apokyn Revenue in Parkinson Disease Drug Business (2016-2021)

11.15.5 Apokyn Recent Development

11.16 Orion

11.16.1 Orion Company Details

11.16.2 Orion Business Overview

11.16.3 Orion Parkinson Disease Drug Introduction

11.16.4 Orion Revenue in Parkinson Disease Drug Business (2016-2021)

11.16.5 Orion Recent Development

11.17 Stada Arzneimittel

11.17.1 Stada Arzneimittel Company Details

11.17.2 Stada Arzneimittel Business Overview

11.17.3 Stada Arzneimittel Parkinson Disease Drug Introduction

11.17.4 Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2016-2021)

11.17.5 Stada Arzneimittel Recent Development

11.18 US WorldMeds

11.18.1 US WorldMeds Company Details

11.18.2 US WorldMeds Business Overview

11.18.3 US WorldMeds Parkinson Disease Drug Introduction

11.18.4 US WorldMeds Revenue in Parkinson Disease Drug Business (2016-2021)

11.18.5 US WorldMeds Recent Development

11.19 Bausch Health

11.19.1 Bausch Health Company Details

11.19.2 Bausch Health Business Overview

11.19.3 Bausch Health Parkinson Disease Drug Introduction

11.19.4 Bausch Health Revenue in Parkinson Disease Drug Business (2016-2021)

11.19.5 Bausch Health Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Parkinson Disease Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

    Table 2. Key Players of Sinemet-CR

    Table 3. Key Players of Trastal

    Table 4. Key Players of Madopar

    Table 5. Key Players of COMT Inhibitor

    Table 6. Key Players of Other

    Table 7. Global Parkinson Disease Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

    Table 8. Global Parkinson Disease Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

    Table 9. Global Parkinson Disease Drug Market Size by Regions (2016-2021) & (US$ Million)

    Table 10. Global Parkinson Disease Drug Market Share by Regions (2016-2021)

    Table 11. Global Parkinson Disease Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 12. Global Parkinson Disease Drug Market Share by Regions (2022-2027)

    Table 13. Parkinson Disease Drug Market Trends

    Table 14. Parkinson Disease Drug Market Drivers

    Table 15. Parkinson Disease Drug Market Challenges

    Table 16. Parkinson Disease Drug Market Restraints

    Table 17. Global Parkinson Disease Drug Revenue by Players (2016-2021) & (US$ Million)

    Table 18. Global Parkinson Disease Drug Market Share by Players (2016-2021)

    Table 19. Global Top Parkinson Disease Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson Disease Drug as of 2020)

    Table 20. Ranking of Global Top Parkinson Disease Drug Companies by Revenue (US$ Million) in 2020

    Table 21. Global 5 Largest Players Market Share by Parkinson Disease Drug Revenue (CR5 and HHI) & (2016-2021)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Parkinson Disease Drug Product Solution and Service

    Table 24. Date of Enter into Parkinson Disease Drug Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)

    Table 27. Global Parkinson Disease Drug Revenue Market Share by Type (2016-2021)

    Table 28. Global Parkinson Disease Drug Forecasted Market Size by Type (2022-2027) (US$ Million)

    Table 29. Global Parkinson Disease Drug Revenue Market Share by Type (2022-2027) & (US$ Million)

    Table 30. Global Parkinson Disease Drug Market Size Share by Application (2016-2021) & (US$ Million)

    Table 31. Global Parkinson Disease Drug Revenue Market Share by Application (2016-2021)

    Table 32. Global Parkinson Disease Drug Forecasted Market Size by Application (2022-2027) (US$ Million)

    Table 33. Global Parkinson Disease Drug Revenue Market Share by Application (2022-2027) & (US$ Million)

    Table 34. North America Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)

    Table 35. North America Parkinson Disease Drug Market Size by Type (2022-2027) & (US$ Million)

    Table 36. North America Parkinson Disease Drug Market Size by Application (2016-2021) (US$ Million)

    Table 37. North America Parkinson Disease Drug Market Size by Application (2022-2027) & (US$ Million)

    Table 38. North America Parkinson Disease Drug Market Size by Country (2016-2021) & (US$ Million)

    Table 39. North America Parkinson Disease Drug Market Size by Country (2022-2027) & (US$ Million)

    Table 40. Europe Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)

    Table 41. Europe Parkinson Disease Drug Market Size by Type (2022-2027) & (US$ Million)

    Table 42. Europe Parkinson Disease Drug Market Size by Application (2016-2021) (US$ Million)

    Table 43. Europe Parkinson Disease Drug Market Size by Application (2022-2027) & (US$ Million)

    Table 44. Europe Parkinson Disease Drug Market Size by Country (2016-2021) & (US$ Million)

    Table 45. Europe Parkinson Disease Drug Market Size by Country (2022-2027) & (US$ Million)

    Table 46. Asia-Pacific Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)

    Table 47. Asia-Pacific Parkinson Disease Drug Market Size by Type (2022-2027) & (US$ Million)

    Table 48. Asia-Pacific Parkinson Disease Drug Market Size by Application (2016-2021) (US$ Million)

    Table 49. Asia-Pacific Parkinson Disease Drug Market Size by Application (2022-2027) & (US$ Million)

    Table 50. Asia-Pacific Parkinson Disease Drug Market Size by Region (2016-2021) & (US$ Million)

    Table 51. Asia-Pacific Parkinson Disease Drug Market Size by Region (2022-2027) & (US$ Million)

    Table 52. Latin America Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)

    Table 53. Latin America Parkinson Disease Drug Market Size by Type (2022-2027) & (US$ Million)

    Table 54. Latin America Parkinson Disease Drug Market Size by Application (2016-2021) (US$ Million)

    Table 55. Latin America Parkinson Disease Drug Market Size by Application (2022-2027) & (US$ Million)

    Table 56. Latin America Parkinson Disease Drug Market Size by Country (2016-2021) & (US$ Million)

    Table 57. Latin America Parkinson Disease Drug Market Size by Country (2022-2027) & (US$ Million)

    Table 58. Middle East & Africa Parkinson Disease Drug Market Size by Type (2016-2021) (US$ Million)

    Table 59. Middle East & Africa Parkinson Disease Drug Market Size by Type (2022-2027) & (US$ Million)

    Table 60. Middle East & Africa Parkinson Disease Drug Market Size by Application (2016-2021) (US$ Million)

    Table 61. Middle East & Africa Parkinson Disease Drug Market Size by Application (2022-2027) & (US$ Million)

    Table 62. Middle East & Africa Parkinson Disease Drug Market Size by Country (2016-2021) & (US$ Million)

    Table 63. Middle East & Africa Parkinson Disease Drug Market Size by Country (2022-2027) & (US$ Million)

    Table 64. Merck Company Details

    Table 65. Merck Business Overview

    Table 66. Merck Parkinson Disease Drug Product

    Table 67. Merck Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 68. Merck Recent Development

    Table 69. Akorn Company Details

    Table 70. Akorn Business Overview

    Table 71. Akorn Parkinson Disease Drug Product

    Table 72. Akorn Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 73. Akorn Recent Development

    Table 74. GSK Company Details

    Table 75. GSK Business Overview

    Table 76. GSK Parkinson Disease Drug Product

    Table 77. GSK Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 78. GSK Recent Development

    Table 79. Novartis Company Details

    Table 80. Novartis Business Overview

    Table 81. Novartis Parkinson Disease Drug Product

    Table 82. Novartis Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 83. Novartis Recent Development

    Table 84. Boehringer Ingelheim Company Details

    Table 85. Boehringer Ingelheim Business Overview

    Table 86. Boehringer Ingelheim Parkinson Disease Drug Product

    Table 87. Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 88. Boehringer Ingelheim Recent Development

    Table 89. Teva Pharmaceutical Company Details

    Table 90. Teva Pharmaceutical Business Overview

    Table 91. Teva Pharmaceutical Parkinson Disease Drug Product

    Table 92. Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 93. Teva Pharmaceutical Recent Development

    Table 94. Abbvie Company Details

    Table 95. Abbvie Business Overview

    Table 96. Abbvie Parkinson Disease Drug Product

    Table 97. Abbvie Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 98. Abbvie Recent Development

    Table 99. Kyowa Hakko Kirin Pharma Company Details

    Table 100. Kyowa Hakko Kirin Pharma Business Overview

    Table 101. Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 102. Kyowa Hakko Kirin Pharma Recent Development

    Table 103. Astellas Pharma Company Details

    Table 104. Astellas Pharma Business Overview

    Table 105. Astellas Pharma Parkinson Disease Drug Product

    Table 106. Astellas Pharma Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 107. Astellas Pharma Recent Development

    Table 108. Desitin Arzneimittel Company Details

    Table 109. Desitin Arzneimittel Business Overview

    Table 110. Desitin Arzneimittel Parkinson Disease Drug Product

    Table 111. Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 112. Desitin Arzneimittel Recent Development

    Table 113. Endo Pharmaceuticals Company Details

    Table 114. Endo Pharmaceuticals Business Overview

    Table 115. Endo Pharmaceuticals Parkinson Disease Drug Product

    Table 116. Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 117. Endo Pharmaceuticals Recent Development

    Table 118. F.Hoffmann-La Roche Company Details

    Table 119. F.Hoffmann-La Roche Business Overview

    Table 120. F.Hoffmann-La Roche Parkinson Disease Drug Product

    Table 121. F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 122. F.Hoffmann-La Roche Recent Development

    Table 123. H.Lundbeck Company Details

    Table 124. H.Lundbeck Business Overview

    Table 125. H.Lundbeck Parkinson Disease Drug Product

    Table 126. H.Lundbeck Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 127. H.Lundbeck Recent Development

    Table 128. Valeant Company Details

    Table 129. Valeant Business Overview

    Table 130. Valeant Parkinson Disease Drug Product

    Table 131. Valeant Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 132. Valeant Recent Development

    Table 133. Apokyn Company Details

    Table 134. Apokyn Business Overview

    Table 135. Apokyn Parkinson Disease Drug Product

    Table 136. Apokyn Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 137. Apokyn Recent Development

    Table 138. Orion Company Details

    Table 139. Orion Business Overview

    Table 140. Orion Parkinson Disease Drug Product

    Table 141. Orion Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 142. Orion Recent Development

    Table 143. Stada Arzneimittel Company Details

    Table 144. Stada Arzneimittel Business Overview

    Table 145. Stada Arzneimittel Parkinson Disease Drug Product

    Table 146. Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 147. Stada Arzneimittel Recent Development

    Table 148. US WorldMeds Company Details

    Table 149. US WorldMeds Business Overview

    Table 150. US WorldMeds Parkinson Disease Drug Product

    Table 151. US WorldMeds Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 152. US WorldMeds Recent Development

    Table 153. Bausch Health Company Details

    Table 154. Bausch Health Business Overview

    Table 155. Bausch Health Parkinson Disease Drug Product

    Table 156. Bausch Health Revenue in Parkinson Disease Drug Business (2016-2021) & (US$ Million)

    Table 157. Bausch Health Recent Development

    Table 158. Research Programs/Design for This Report

    Table 159. Key Data Information from Secondary Sources

    Table 160. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Parkinson Disease Drug Market Share by Type: 2020 VS 2027

    Figure 2. Sinemet-CR Features

    Figure 3. Trastal Features

    Figure 4. Madopar Features

    Figure 5. COMT Inhibitor Features

    Figure 6. Other Features

    Figure 7. Global Parkinson Disease Drug Market Share by Application: 2020 VS 2027

    Figure 8. Under 40 Years Old Case Studies

    Figure 9. 40-65 Years Old Case Studies

    Figure 10. Above 65 Years Old Case Studies

    Figure 11. Parkinson Disease Drug Report Years Considered

    Figure 12. Global Parkinson Disease Drug Market Size (US$ Million), Year-over-Year: 2016-2027

    Figure 13. Global Parkinson Disease Drug Market Size (US$ Million), 2016 VS 2021 VS 2027

    Figure 14. Global Parkinson Disease Drug Market Share by Regions: 2020 VS 2027

    Figure 15. Global Parkinson Disease Drug Market Share by Regions (2022-2027)

    Figure 16. Global Parkinson Disease Drug Market Share by Players in 2020

    Figure 17. Global Top Parkinson Disease Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson Disease Drug as of 2020

    Figure 18. The Top 10 and 5 Players Market Share by Parkinson Disease Drug Revenue in 2020

    Figure 19. Global Parkinson Disease Drug Revenue Market Share by Type (2016-2021)

    Figure 20. Global Parkinson Disease Drug Revenue Market Share by Type (2022-2027)

    Figure 21. North America Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 22. North America Parkinson Disease Drug Market Share by Type (2016-2027)

    Figure 23. North America Parkinson Disease Drug Market Share by Application (2016-2027)

    Figure 24. North America Parkinson Disease Drug Market Share by Country (2016-2027)

    Figure 25. United States Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 26. Canada Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 27. Europe Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 28. Europe Parkinson Disease Drug Market Share by Type (2016-2027)

    Figure 29. Europe Parkinson Disease Drug Market Share by Application (2016-2027)

    Figure 30. Europe Parkinson Disease Drug Market Share by Country (2016-2027)

    Figure 31. Germany Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 32. France Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 33. U.K. Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 34. Italy Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 35. Russia Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 36. Nordic Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 37. Asia-Pacific Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 38. Asia-Pacific Parkinson Disease Drug Market Share by Type (2016-2027)

    Figure 39. Asia-Pacific Parkinson Disease Drug Market Share by Application (2016-2027)

    Figure 40. Asia-Pacific Parkinson Disease Drug Market Share by Region (2016-2027)

    Figure 41. China Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 42. Japan Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 43. South Korea Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 44. Southeast Asia Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 45. India Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 46. Australia Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 47. Latin America Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 48. Latin America Parkinson Disease Drug Market Share by Type (2016-2027)

    Figure 49. Latin America Parkinson Disease Drug Market Share by Application (2016-2027)

    Figure 50. Latin America Parkinson Disease Drug Market Share by Country (2016-2027)

    Figure 51. Mexico Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 52. Brazil Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 53. Middle East & Africa Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 54. Middle East & Africa Parkinson Disease Drug Market Share by Type (2016-2027)

    Figure 55. Middle East & Africa Parkinson Disease Drug Market Share by Application (2016-2027)

    Figure 56. Middle East & Africa Parkinson Disease Drug Market Share by Country (2016-2027)

    Figure 57. Turkey Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 58. Saudi Arabia Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 59. UAE Parkinson Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 60. Merck Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 61. Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 62. GSK Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 63. Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 64. Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 65. Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 66. Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 67. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 68. Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 69. Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 70. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 71. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 72. H.Lundbeck Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 73. Valeant Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 74. Apokyn Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 75. Orion Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 76. Stada Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 77. US WorldMeds Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 78. Bausch Health Revenue Growth Rate in Parkinson Disease Drug Business (2016-2021)

    Figure 79. Bottom-up and Top-down Approaches for This Report

    Figure 80. Data Triangulation

    Figure 81. Key Executives Interviewed